BioPharma Dealmakers is published quarterly in both Nature Biotechnology and Nature Reviews Drug Discovery. MedTech Dealmakers is also published in Nature Medicine.
Nature Biotechnology is a monthly journal covering the science and business of biotechnology. It publishes new concepts in technology/methodology of relevance to the biological, biomedical, agricultural and environmental sciences as well as covers the commercial, political, ethical, legal, and societal aspects of this research.
The 2018 impact factor for Nature Biotechnology is 31.864, according to Clarivate Analytics' Journal Citation Reports (JCR). This places Nature Biotechnology among some of the top journals in the field of biotechnology.
Visit Nature Biotechnology
Nature Reviews Drug Discovery
Nature Reviews Drug Discovery is a monthly journal aimed at everyone working in the drug discovery and development arena. In addition to the highest-quality reviews and perspectives covering the entire field, each issue includes news stories that investigate the hottest topics in drug discovery, timely summaries of key primary research papers, and concise updates on the latest advances in fast-moving areas such as new drug approvals, patent law and emerging industry trends.
Nature Medicine publishes original research articles that range from basic findings that have clear implications for disease pathogenesis and therapy to the earliest phases of human investigation. Aiming to keep Ph.D. and M.D. readers informed of a wide range of biomedical research findings, the journal publishes the latest advances in cancer biology, vascular biology, neuroscience, inflammatory disease, infectious disease and metabolic disorders, among other fields.
Visit Nature Medicine